交易 Nautilus Biotechnology, Inc. - NAUT CFD
加入收藏夹- 概括
- 历史数据
- 活动
- 收入报表
- 资产负债表
- 现金流
- 所有权
交易条件
价差 | - | ||||||||
多头隔夜费
Long position overnight fee
前往平台 | -0.024068% | ||||||||
空头隔夜费
Short position overnight fee
前往平台 | 0.001846% | ||||||||
隔夜费时间 | 21:00 (UTC) | ||||||||
最小交易量 | 1 | ||||||||
货币 | USD | ||||||||
保证金 | 20% | ||||||||
上市交易所 | United States of America | ||||||||
交易费 | 0% |
*Information provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | 平倉 | Change | Change (%) | 開倉 | High | Low |
---|
Nautilus Biotechnology, Inc. Events
時間(協調世界時) (UTC) | 國家 | 事件 |
---|---|---|
No events scheduled |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|
总收入 | 0 | 0 | 0 | 0 |
总营业费用 | 63.618 | 50.498 | 15.744 | 10.11 |
销售/一般/行政费用,总计 | 25.946 | 21.146 | 3.312 | 1.622 |
研究与开发 | 36.472 | 28.352 | 12.432 | 8.488 |
营业收入 | -63.618 | -50.498 | -15.744 | -10.11 |
其他,净值 | -0.122 | 0.183 | 0.125 | 0.492 |
税前净收入 | -57.924 | -50.315 | -15.619 | -9.618 |
税后净收入 | -57.924 | -50.315 | -15.619 | -9.618 |
未计算非常项目前的净收益 | -57.924 | -50.315 | -15.619 | -9.618 |
净收入 | -57.924 | -50.315 | -15.619 | -9.618 |
普通股股东可获收益 (不含非经常性项目) | -57.924 | -50.315 | -15.619 | -9.618 |
普通股股东可获收益 (含非經常性項目) | -57.924 | -50.315 | -15.619 | -9.618 |
摊薄净收入 | -57.924 | -50.315 | -15.619 | -9.618 |
摊薄后加权平均股 | 124.59 | 124.303 | 124.094 | 124.094 |
扣除特别项目的每股摊薄盈利 | -0.46492 | -0.40478 | -0.12586 | -0.07751 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | |
每股正常摊薄盈利 | -0.46492 | -0.40478 | -0.12586 | -0.07751 |
Depreciation / Amortization | 1.2 | 1 | ||
利息收入(费用),非经营净值 | 5.816 |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
---|---|---|---|---|---|
总收入 | 0 | 0 | 0 | 0 | 0 |
总营业费用 | 16.304 | 15.82 | 15.472 | 16.022 | 16.816 |
销售/一般/行政费用,总计 | 6.717 | 6.249 | 6.616 | 6.364 | 6.923 |
研究与开发 | 9.587 | 9.571 | 8.856 | 9.658 | 9.893 |
营业收入 | -16.304 | -15.82 | -15.472 | -16.022 | -16.816 |
其他,净值 | 0.009 | -0.132 | 0.783 | 0.259 | 0.127 |
税前净收入 | -13.409 | -14.063 | -14.689 | -15.763 | -16.689 |
税后净收入 | -13.409 | -14.063 | -14.689 | -15.763 | -16.689 |
未计算非常项目前的净收益 | -13.409 | -14.063 | -14.689 | -15.763 | -16.689 |
净收入 | -13.409 | -14.063 | -14.689 | -15.763 | -16.689 |
普通股股东可获收益 (不含非经常性项目) | -13.409 | -14.063 | -14.689 | -15.763 | -16.689 |
普通股股东可获收益 (含非經常性項目) | -13.409 | -14.063 | -14.689 | -15.763 | -16.689 |
摊薄净收入 | -13.409 | -14.063 | -14.689 | -15.763 | -16.689 |
摊薄后加权平均股 | 124.792 | 124.651 | 124.494 | 124.419 | 124.303 |
扣除特别项目的每股摊薄盈利 | -0.10745 | -0.11282 | -0.11799 | -0.12669 | -0.13426 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常摊薄盈利 | -0.10745 | -0.11282 | -0.11799 | -0.12669 | -0.13426 |
利息收入(费用),非经营净值 | 2.886 | 1.889 |
- 年度
- 每季度
2021 | 2020 | 2019 | |
---|---|---|---|
流动资产总额 | 349.222 | 77.659 | 16.964 |
现金和短期投资 | 345.729 | 76.742 | 16.659 |
现金等价物 | 185.619 | 36.607 | 0.595 |
短期投资 | 160.11 | 40.135 | 16.064 |
Prepaid Expenses | 3.493 | 0.917 | 0.305 |
Total Assets | 398.45 | 85.011 | 18.542 |
Property/Plant/Equipment, Total - Net | 31.86 | 6.213 | 1.119 |
Property/Plant/Equipment, Total - Gross | 33.854 | 7.498 | 1.868 |
Accumulated Depreciation, Total | -1.994 | -1.285 | -0.749 |
Other Long Term Assets, Total | 0.997 | 1.139 | 0.459 |
Total Current Liabilities | 5.812 | 3.018 | 0.49 |
Accounts Payable | 1.723 | 0.47 | 0.289 |
Accrued Expenses | 4.089 | 2.548 | 0.201 |
Notes Payable/Short Term Debt | 0 | 0 | 0 |
Total Liabilities | 34.874 | 6.314 | 0.49 |
Total Long Term Debt | 0 | 0 | 0 |
Other Liabilities, Total | 29.062 | 3.296 | 0 |
Total Equity | 363.576 | 78.697 | 18.052 |
Preferred Stock - Non Redeemable, Net | 0 | 108.418 | 32.561 |
Common Stock | 0.012 | 0.001 | 0.001 |
Additional Paid-In Capital | 444.388 | 0.6 | 0.189 |
Retained Earnings (Accumulated Deficit) | -80.64 | -30.325 | -14.706 |
Other Equity, Total | -0.184 | 0.003 | 0.007 |
Total Liabilities & Shareholders’ Equity | 398.45 | 85.011 | 18.542 |
Total Common Shares Outstanding | 124.303 | 124.094 | 124.094 |
Long Term Investments | 16.371 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
流动资产总额 | 327.065 | 349.222 | 352.222 | 374.628 | 69.445 |
现金和短期投资 | 324.117 | 345.729 | 347.345 | 373.144 | 67.837 |
现金等价物 | 188.622 | 185.619 | 190.241 | 288.387 | 51.803 |
短期投资 | 135.495 | 160.11 | 157.104 | 84.757 | 16.034 |
Prepaid Expenses | 2.948 | 3.493 | 4.877 | 1.484 | 1.608 |
Total Assets | 384.673 | 398.45 | 385.347 | 393.275 | 76.148 |
Property/Plant/Equipment, Total - Net | 31.693 | 31.86 | 5.731 | 2.769 | 2.889 |
Property/Plant/Equipment, Total - Gross | 33.968 | 33.854 | 7.772 | 4.533 | 4.388 |
Accumulated Depreciation, Total | -2.275 | -1.994 | -2.041 | -1.764 | -1.499 |
Other Long Term Assets, Total | 0.997 | 0.997 | 0.767 | 0.612 | 3.814 |
Total Current Liabilities | 6.406 | 5.812 | 4.209 | 3.231 | 4.525 |
Accounts Payable | 1.487 | 1.723 | 1.498 | 1.229 | 2.12 |
Accrued Expenses | 4.919 | 4.089 | 2.711 | 2.002 | 2.405 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 34.964 | 34.874 | 7.5 | 3.231 | 4.525 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Liabilities, Total | 28.558 | 29.062 | 3.291 | 0 | 0 |
Total Equity | 349.709 | 363.576 | 377.847 | 390.044 | 71.623 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 108.418 | ||
Common Stock | 0.012 | 0.012 | 0.012 | 0.012 | 0.001 |
Additional Paid-In Capital | 446.654 | 444.388 | 441.795 | 439.489 | 1.936 |
Retained Earnings (Accumulated Deficit) | -96.403 | -80.64 | -63.951 | -49.447 | -38.734 |
Other Equity, Total | -0.554 | -0.184 | -0.009 | -0.01 | 0.002 |
Total Liabilities & Shareholders’ Equity | 384.673 | 398.45 | 385.347 | 393.275 | 76.148 |
Total Common Shares Outstanding | 124.457 | 124.303 | 124.094 | 124.094 | 124.094 |
Long Term Investments | 24.918 | 16.371 | 26.627 | 15.266 |
- 年度
- 每季度
2021 | 2020 | 2019 | |
---|---|---|---|
净收入/起跑线 | -50.315 | ||
经营活动产生的现金 | -39.241 | ||
经营活动产生的现金 | 1.019 | ||
非现金物品 | 10.077 | ||
营运资金的变化 | -0.022 | ||
投资活动产生的现金 | -138.964 | ||
资本支出 | -2.269 | ||
其他投资现金流量项目,总计 | -136.695 | ||
融资活动产生的现金 | 327.447 | ||
融资现金流项目 | 327.28 | ||
股票的发行(报废),净额 | 0.167 | ||
现金净变化 | 149.242 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -15.763 | -50.315 | -33.626 | -19.122 | -8.409 |
Cash From Operating Activities | -12.335 | -39.241 | -28.722 | -14.545 | -6.253 |
Cash From Operating Activities | 0.281 | 1.019 | 0.756 | 0.479 | 0.214 |
Non-Cash Items | 2.661 | 10.077 | 6.811 | 4.129 | 1.864 |
Changes in Working Capital | 0.486 | -0.022 | -2.663 | -0.031 | 0.078 |
Cash From Investing Activities | 15.182 | -138.964 | -145.028 | -61.048 | 23.518 |
Other Investing Cash Flow Items, Total | 15.663 | -136.695 | -143.745 | -60.035 | 23.518 |
Cash From Financing Activities | 0.156 | 327.447 | 327.384 | 327.373 | -2.069 |
Financing Cash Flow Items | 0 | 327.28 | 327.28 | 327.327 | -2.069 |
Net Change in Cash | 3.003 | 149.242 | 153.634 | 251.78 | 15.196 |
Capital Expenditures | -0.481 | -2.269 | -1.283 | -1.013 | |
Issuance (Retirement) of Stock, Net | 0.156 | 0.167 | 0.104 | 0.046 |
投资者名称 | 投资者类型 | 流通股百分比 | 持有股份 | 股份变动 | 持有日期 | 换手率 |
---|---|---|---|---|---|---|
Mallick (Parag) | Individual Investor | 16.5616 | 20679892 | 200000 | 2022-04-18 | LOW |
Patel (Sujal M) | Individual Investor | 13.7018 | 17108999 | 0 | 2023-02-27 | LOW |
Perceptive Advisors LLC | Private Equity | 7.2967 | 9111151 | 0 | 2022-12-31 | MED |
Cercano Management LLC | Investment Advisor | 5.7445 | 7172985 | 7172985 | 2022-12-31 | |
Vulcan Capital Management Inc | Corporation | 5.7445 | 7172985 | 0 | 2022-04-18 | |
Madrona Venture Group, LLC | Venture Capital | 4.8218 | 6020770 | 0 | 2022-12-31 | LOW |
ARYA Sciences Holdings III | Corporation | 3.3207 | 4146500 | 3647500 | 2022-04-18 | |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 2.1231 | 2651020 | 144356 | 2022-12-31 | LOW |
Comprehensive Financial Management LLC | Investment Advisor | 1.7816 | 2224619 | 0 | 2022-12-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 1.7422 | 2175376 | -1313 | 2022-12-31 | LOW |
Bain Capital Life Sciences Investors, LLC | Investment Advisor | 1.6017 | 2000000 | 0 | 2022-12-31 | LOW |
Nazem (Farzad) | Individual Investor | 1.5121 | 1888146 | 0 | 2022-04-18 | LOW |
Tikvah Management LLC | Hedge Fund | 1.1924 | 1488895 | 0 | 2022-12-31 | LOW |
Amazon.com Inc | Investment Advisor | 1.1669 | 1457055 | 0 | 2022-12-31 | LOW |
ArchPoint Investors, LLC | Investment Advisor | 1.1609 | 1449551 | 0 | 2022-12-31 | LOW |
Andreessen Horowitz | Venture Capital | 1.0859 | 1355911 | -16298006 | 2022-12-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.7695 | 960868 | 5799 | 2022-12-31 | LOW |
Rubric Capital Management LP | Hedge Fund | 0.5987 | 747607 | 0 | 2022-12-31 | MED |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.5624 | 702204 | 49879 | 2022-12-31 | LOW |
RTW Investments L.P. | Investment Advisor/Hedge Fund | 0.4805 | 600000 | 0 | 2022-12-31 | LOW |
交易計算器
如果您在特定日期(选择一个日期)开立差价合约交易并在不同日期(选择一个日期)关闭交易,计算您的假设盈亏。
貿易佣金
0
- 1:1
杠杆
1:1
- 20
- 100
- 500
- 1000
- 10000
投資
交易規模(槓桿 x 投資):
開倉
平倉
做空 做多
Nautilus Biotechnology, Inc. Company profile
关于 Nautilus Biotechnology Inc.
Nautilus 生物技术公司是一家处于发展阶段的生命科学公司。 该公司从事创建一个平台技术,用于量化和解锁人类蛋白质组的复杂性。 公司专注于通过普及蛋白质组的使用来改变蛋白质组学领域,并使整个人类健康和医学取得根本性的进步。 其平台的端到端解决方案由蛋白质组分析系统、耗材和软件组成。 公司正在开发一个单分子仪器的原型--蛋白质组分析系统。 公司的蛋白质组分析平台利用纳米制造的单分子蛋白质阵列、多周期成像和机器学习分析来识别和测量具有灵敏度和规模的蛋白质组。
Industry: | Biotechnology & Medical Research (NEC) |
2701 Eastlake Ave East
Suite 202
SEATTLE
WASHINGTON 98102
US
收入报表
- Annual
- Quarterly
人们也观看
还在找一位您可以信任的经纪商吗?
加入成为全球500,000万多名交易者的一份子,选择利用Capital.com进行交易吧。